CTHRC1 affects malignant tumor cell behavior and is regulated by miR-30e-5p in human prostate cancer
Authors:
Open Access
- 1 April 2020
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 525 (2) , 418-424
Abstract
No abstract availableKeywords
Funding Information
- Natural Science Foundation of Shanghai Municipality (18ZR1405800)
This publication has 31 references indexed in Scilit:
- Osteoclast-secreted CTHRC1 in the coupling of bone resorption to formationJournal of Clinical Investigation, 2013
- Overexpression of CTHRC1 in Hepatocellular Carcinoma Promotes Tumor Invasion and Predicts Poor PrognosisPLOS ONE, 2013
- Cthrc1, a Novel Circulating Hormone Regulating MetabolismPLOS ONE, 2012
- Wnt/β-catenin signaling accelerates mouse lung tumorigenesis by imposing an embryonic distal progenitor phenotype on lung epitheliumJournal of Clinical Investigation, 2011
- Collagen triple helix repeat containing-1 inhibits transforming growth factor-β1-induced collagen type I expression in keloidBritish Journal of Dermatology, 2011
- Lead Time and Overdiagnosis in Prostate-Specific Antigen Screening: Importance of Methods and ContextJNCI: Journal of the National Cancer Institute, 2009
- Cthrc1 Is a Positive Regulator of Osteoblastic Bone FormationPLOS ONE, 2008
- microRNAs as oncogenes and tumor suppressorsDevelopmental Biology, 2007
- Aberrant Expression of Collagen Triple Helix Repeat Containing 1 in Human Solid CancersClinical Cancer Research, 2006
- Mechanisms Underlying the Development of Androgen-Independent Prostate CancerClinical Cancer Research, 2006